Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$0.28 - $1.16 $53,574 - $221,949
191,336 Added 653.67%
220,607 $73.7 Million
Q1 2024

May 08, 2024

SELL
$1.06 - $1.67 $53 - $83
-50 Reduced 0.17%
29,271 $34 Million
Q4 2023

Feb 12, 2024

BUY
$1.26 - $1.79 $36,944 - $52,484
29,321 New
29,321 $49.6 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Pine Valley Investments LTD Liability CO Portfolio

Follow Pine Valley Investments LTD Liability CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Valley Investments LTD Liability CO, based on Form 13F filings with the SEC.

News

Stay updated on Pine Valley Investments LTD Liability CO with notifications on news.